Repligen Corp

Затворен

СекторЗдравеопазване

166.1 -0.46

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

165.77

Максимум

167.39

Ключови измерители

By Trading Economics

Приходи

-3.3M

5M

Продажби

9.9M

204M

P/E

Средно за сектора

223.521

57.002

EPS

0.54

Марж на печалбата

2.453

Служители

2,000

EBITDA

-35M

-2.4M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+3.37% upside

Дивиденти

By Acuity

Следващи печалби

27.10.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.8B

9.2B

Предишно отваряне

166.56

Предишно затваряне

166.1

Настроения в новините

By Acuity

50%

50%

142 / 340 Класиране в Healthcare

Repligen Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.08.2026 г., 19:16 ч. UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13.08.2026 г., 22:01 ч. UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12.08.2026 г., 19:36 ч. UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11.08.2026 г., 20:01 ч. UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10.08.2026 г., 23:16 ч. UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7.08.2026 г., 22:01 ч. UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6.08.2026 г., 20:02 ч. UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5.08.2026 г., 20:02 ч. UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4.08.2026 г., 19:56 ч. UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31.07.2026 г., 20:02 ч. UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30.07.2026 г., 21:02 ч. UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29.07.2026 г., 16:12 ч. UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28.07.2026 г., 23:21 ч. UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27.07.2026 г., 16:26 ч. UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

24.07.2026 г., 19:06 ч. UTC

News

Repligen Corp is under scrutiny as a stock to avoid, with concerns over its $763.3 million revenue and declining operating margins. Shares are trading lower today.

22.07.2026 г., 19:25 ч. UTC

News
Event
Social Media

Repligen Corp is acquiring BioLife Solutions for about $1.5 billion, offering $11.25 in cash and stock, with a projected $20 million in synergies.

21.07.2026 г., 22:56 ч. UTC

Repligen Corp shares are higher in after-market trading, despite a recent trend of lower closes. Broader market sentiment may be influenced by the Nikkei 225 surge.

20.07.2026 г., 18:06 ч. UTC

Repligen Corp shares are higher today, reflecting positive market sentiment despite earlier intraday fluctuations. No specific news was identified to explain the movement.

Сравнение с други в отрасъла

Ценова промяна

Repligen Corp Прогноза

Ценова цел

By TipRanks

3.37% нагоре

12-месечна прогноза

Среден 172.45 USD  3.37%

Висок 207 USD

Нисък 145 USD

Според 13 анализатори от Wall Street, предложили 12-месечна ценова цел за Repligen Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

13 ratings

12

Купи

1

Задържане

0

Продай

Настроение

By Acuity

142 / 340 Класиране в Здравеопазване

Настроения в новините

Neutral

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat